Literature DB >> 18182052

Xanthurenic acid distribution, transport, accumulation and release in the rat brain.

Serge Gobaille1, Véronique Kemmel, Daniel Brumaru, Christophe Dugave, Dominique Aunis, Michel Maitre.   

Abstract

Tryptophan metabolism through the kynurenine pathway leads to several neuroactive compounds, including kynurenic and picolinic acids. Xanthurenic acid (Xa) has been generally considered as a substance with no physiological role but possessing toxic and apoptotic properties. In the present work, we present several findings which support a physiological role for endogenous Xa in synaptic signalling in brain. This substance is present in micromolar amounts in most regions of the rat brain with a heterogeneous distribution. An active vesicular synaptic process inhibited by bafilomycin and nigericin accumulates xanthurenate into pre-synaptic terminals. A neuronal transport, partially dependant on adenosine 5'-triphosphate (ATP), sodium and chloride ions exists in NCB-20 neurons which could participate in the clearance of extracellular xanthurenate. Both transports (neuronal and vesicular) are greatly enhanced by the presence of micromolar amounts of zinc ions. Finally, electrical in vivo stimulation of A10-induced Xa release in the extracellular spaces of the rat prefrontal cortex. This phenomenon is reproduced by veratrine, K+ ions and blocked by EGTA and tetrodotoxin. These results strongly argue for a role for Xa in neurotransmission/neuromodulation in the rat brain, thus providing the existence of specific Xa receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18182052     DOI: 10.1111/j.1471-4159.2008.05219.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  28 in total

Review 1.  Where does a migraine attack originate? In the brainstem.

Authors:  J Tajti; D Szok; Á Párdutz; B Tuka; A Csáti; A Kuris; J Toldi; L Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2012-03-18       Impact factor: 3.575

2.  Deficit, but Not Nondeficit, Schizophrenia Is Characterized by Mucosa-Associated Activation of the Tryptophan Catabolite (TRYCAT) Pathway with Highly Specific Increases in IgA Responses Directed to Picolinic, Xanthurenic, and Quinolinic Acid.

Authors:  Buranee Kanchanatawan; Sunee Sirivichayakul; Kiat Ruxrungtham; André F Carvalho; Michel Geffard; Heidi Ormstad; George Anderson; Michael Maes
Journal:  Mol Neurobiol       Date:  2017-02-08       Impact factor: 5.590

3.  Xanthurenic Acid Formation from 3-Hydroxykynurenine in the Mammalian Brain: Neurochemical Characterization and Physiological Effects.

Authors:  K V Sathyasaikumar; M Tararina; H-Q Wu; S A Neale; F Weisz; T E Salt; R Schwarcz
Journal:  Neuroscience       Date:  2017-10-12       Impact factor: 3.590

Review 4.  Kynurenines and headache.

Authors:  Arpád Párdutz; Annamária Fejes; Zsuzsanna Bohár; Lilla Tar; József Toldi; László Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2011-06-04       Impact factor: 3.575

5.  Changes in serum levels of kynurenine metabolites in paediatric patients affected by ADHD.

Authors:  Melania Evangelisti; Pietro De Rossi; Jole Rabasco; Renato Donfrancesco; Luana Lionetto; Matilde Capi; Gabriele Sani; Maurizio Simmaco; Ferdinando Nicoletti; Maria Pia Villa
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-05-19       Impact factor: 4.785

Review 6.  Fathoming the kynurenine pathway in migraine: why understanding the enzymatic cascades is still critically important.

Authors:  Martina Curto; Luana Lionetto; Francesco Fazio; Dimos-Dimitrios Mitsikostas; Paolo Martelletti
Journal:  Intern Emerg Med       Date:  2015-02-24       Impact factor: 3.397

7.  Kynurenic acid and 3-hydroxykynurenine production from D-kynurenine in mice.

Authors:  Xiao-Dan Wang; Francesca M Notarangelo; Ji-Zuo Wang; Robert Schwarcz
Journal:  Brain Res       Date:  2012-03-17       Impact factor: 3.252

8.  Circulating Antibodies to IDO/THO Pathway Metabolites in Alzheimer's Disease.

Authors:  S Duleu; A Mangas; F Sevin; B Veyret; A Bessede; M Geffard
Journal:  Int J Alzheimers Dis       Date:  2010-03-15

9.  Tetrahydrobiopterin Biosynthesis as a Potential Target of the Kynurenine Pathway Metabolite Xanthurenic Acid.

Authors:  Hirohito Haruki; Ruud Hovius; Miriam Grønlund Pedersen; Kai Johnsson
Journal:  J Biol Chem       Date:  2015-11-12       Impact factor: 5.157

10.  Modulation of hippocampal synaptic transmission by the kynurenine pathway member xanthurenic acid and other VGLUT inhibitors.

Authors:  S A Neale; C S Copeland; V N Uebele; F J Thomson; T E Salt
Journal:  Neuropsychopharmacology       Date:  2013-01-07       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.